TCM
NVO

Telos Capital Management’s Novo Nordisk NVO Stock Holding History

Telos Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
+4,968
New +$213K 0.02% 191
2026
Q1 		– Sell
-4,519
Closed -$230K – 198
2025
Q4 		$230K Buy
4,519
+117
+3% +$5.98K 0.02% 187
2025
Q3 		$244K Buy
+4,402
New +$258K 0.02% 180

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Telos Capital Management's NVO Position: Q2 2026 in Review

Telos Capital Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,968 shares worth $238K. The stake represents 0.02% of the portfolio and ranks #191 among its holdings. This is a return to the name: Telos Capital Management previously reported a position in NVO as recently as Q4 2025.

Telos Capital Management first reported a position in NVO in Q3 2025 and has held it in 3 quarters since. The position peaked at $244K in Q3 2025. 433 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Telos Capital Management held 4,968 shares of Novo Nordisk worth $238K as of Q2 2026.
  • Novo Nordisk was a new Telos Capital Management position in Q2 2026.
  • Novo Nordisk made up 0.02% of Telos Capital Management's portfolio in Q2 2026, its #191 holding.
  • Telos Capital Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 3 quarters since.
  • Telos Capital Management's Novo Nordisk position peaked at $244K in Q3 2025.
  • 433 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.